Latest Research Reports

Early detection of invasive breast cancer substandard in urban China

Early detection of invasive breast cancer substandard in urban China

Despite challenges, pain-related indications are most frequently researched clinical trials

Despite challenges, pain-related indications are most frequently researched clinical trials

Non-industry trials were more frequent than industry trials in 2016

Non-industry trials were more frequent than industry trials in 2016

Chlamydia testing, one step back but two steps forward

Chlamydia testing, one step back but two steps forward

Which class of drugs is set to have the biggest impact on the cancer market?

Which class of drugs is set to have the biggest impact on the cancer market?

Monoclonal antibodies make up seven out of the top ten investigated drugs in 2016

Monoclonal antibodies make up seven out of the top ten investigated drugs in 2016

Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space

Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space

EMA set to approve plethora of oncology drugs

EMA set to approve plethora of oncology drugs

Top indications and therapy areas for 2012-2016 clinical trials in Israel

Top indications and therapy areas for 2012-2016 clinical trials in Israel

Orphan cancer drugs take up 37% of market share

Orphan cancer drugs take up 37% of market share

US and UK stand out with higher disease prevalence of two autoimmune diseases

US and UK stand out with higher disease prevalence of two autoimmune diseases

Is diagnosed non-invasive ductal carcinoma in-situ breast cancer rarer in China?

Is diagnosed non-invasive ductal carcinoma in-situ breast cancer rarer in China?

Anticipated approval timeline of PARP inhibitors in HER2-negative breast cancer

Anticipated approval timeline of PARP inhibitors in HER2-negative breast cancer

Cost containment remains strategic driver in outsourcing sector

Total combined peer group operating margin increased by 100 basis points to 12.4% of total sales in 2016, which represented three consecutive years of margin improvement in the outsourcing...

Cost containment remains strategic driver in outsourcing sector

Industry-sponsored clinical trials initiated in Q1 2017

Industry-sponsored clinical trials initiated in Q1 2017

China shows leading emerging market growth in R&D spend

While the global pharmaceutical markets have typically been dominated by US, Europe and Japan, emerging markets have been steadily increasing their prominence in the global space over the...

China shows leading emerging market growth in R&D spend

Innovative new drugs could produce a watershed moment for dermatology sufferers

Innovative new drugs could produce a watershed moment for dermatology sufferers

Brazil: 2016 clinical trials activity at lowest point in five years

Brazil: 2016 clinical trials activity at lowest point in five years

A serious threat on the horizon for Imbruvica

A serious threat on the horizon for Imbruvica

India’s 2016 clinical trials activity back to 2008 levels

India’s 2016 clinical trials activity back to 2008 levels

UK and Australian health authorities disagree over E-cigarettes

UK and Australian health authorities disagree over E-cigarettes